These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31888747)

  • 1. Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q
    Ferreira PL; Gonçalo M; Ferreira JA; Costa AC; Todo-Bom A; Abreu CL; Travassos AR; Andrade P; Baiardini I; Canonica GW
    Health Qual Life Outcomes; 2019 Dec; 17(1):190. PubMed ID: 31888747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation and validation of the Bengali version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Dhabal A; Mondal H; Mondal S; Baiardini I; Chakraborty SS; Chakraborty T; Podder I
    Indian J Dermatol Venereol Leprol; 2023; 89(3):385-392. PubMed ID: 36331856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.
    Dias GA; Pires GV; Valle SO; França AT; Papi JA; Dortas SD; Levy SA; Baiardini I; Canonica GW
    Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese version of the chronic urticaria quality of life questionnaire: cultural adaptation, factor analysis, assessment of reliability and validity.
    Zhao Z; Zhang C; Jiang Y; Peng C; Zhu W; Zhao S; Chen X; Li J
    Arch Dermatol Res; 2022 Nov; 314(9):847-855. PubMed ID: 34739561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kulthanan K; Chularojanamontri L; Tuchinda P; Rujitharanawong C; Baiardini I; Braido F
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):137-45. PubMed ID: 27007835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kessel A; Graif Y; Vadasz Z; Schichter-Konfino V; Almog M; Cohen S; Teplitski V; Stein N; Baiardini I; Maurer M; Toubi E
    Isr Med Assoc J; 2016 Aug; 18(8):461-465. PubMed ID: 28471576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.
    Tawil S; Irani C; Kfoury R; Salameh P; Baiardini I; Weller K; Maurer M; Ezzedine K
    Int J Dermatol; 2020 Aug; 59(8):893-901. PubMed ID: 32638368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
    Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M
    Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Valero A; Herdman M; Bartra J; Ferrer M; Jáuregui I; Dávila I; del Cuvillo A; Montoro J; Mullol J; Sastre J; Canonica GW; Baiardini I
    J Investig Allergol Clin Immunol; 2008; 18(6):426-32. PubMed ID: 19123433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.
    Tavakol M; Mohammadinejad P; Baiardini I; Braido F; Gharagozlou M; Aghamohammadi A; Nabavi M; Dabbaghzade A; Tavakol Z; Afarideh M; Rezaei N
    Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):278-85. PubMed ID: 24659164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT).
    Khoshkhui M; Weller K; Fadaee J; Maurer M; Jabbari Azad F; Emadzadeh M
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):423-431. PubMed ID: 34418896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
    World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
    Koti I; Weller K; Makris M; Tiligada E; Psaltopoulou T; Papageorgiou C; Baiardini I; Panagiotakos D; Braido F; Maurer M
    Dermatology; 2013; 226(4):371-9. PubMed ID: 23942323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation, cross-cultural adaptation and validation of the Osteoarthritis Quality of Life (OAQoL) questionnaire for use in Portugal.
    Gomes JL; Águeda AF; Heaney A; Duarte C; Lopes C; Costa T; Marona J; Rodrigues-Manica S; Maia S; Costa M; Branco JC; McKenna SP; Barcelos A; Pimentel-Santos FM
    Rheumatol Int; 2019 Apr; 39(4):715-722. PubMed ID: 30415453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
    Salman A; Demir G; Bekiroglu N
    Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the Indonesian version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Nuary T; Budianti WK; Indriatmi W; Baiardini I
    Asian Pac J Allergy Immunol; 2021 Jul; ():. PubMed ID: 34246221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity and reliability of the Thai-version of 5-D itch scale.
    Tuchinda P; Kulthanan K; Chularojanamontri L; Rujitharanawong C; Subchookul C; Trakanwittayarak S
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):254-262. PubMed ID: 32247306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member.
    Elsner SA; Salek SS; Finlay AY; Hagemeier A; Bottomley CJ; Katalinic A; Waldmann A
    Health Qual Life Outcomes; 2021 Mar; 19(1):106. PubMed ID: 33761949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
    Gimenez-Arnau A; Bartra J; Ferrer M; Jauregui I; Borbujo J; Figueras I; Muñoz-Bellido FJ; Pedraz J; Serra-Baldrich E; Tejedor-Alonso MA; Velasco M; Terradas P; Labrador M
    J Investig Allergol Clin Immunol; 2022 Jun; 32(3):191-199. PubMed ID: 33349612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.